Abingdon Health (LON:ABDX) Trading Down 5.3% – What’s Next?

Shares of Abingdon Health Plc (LON:ABDX) traded down 5.3% during trading on Wednesday . The company traded as low as GBX 9 and last traded at GBX 9. 173,186 shares changed hands during mid-day trading, a decline of 20% from the average session volume of 216,626 shares. The stock had previously closed at GBX 9.50.

Abingdon Health Trading Down 10.0%

The stock has a market capitalization of £21.47 million, a PE ratio of -10.56 and a beta of 0.25. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The business’s 50-day moving average is GBX 7.99 and its two-hundred day moving average is GBX 7.04.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) EPS for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.